Market News AIOpen the app

Viatris has finished buying Pacira BioSciences, owning about 66.46% of its shares now.

DealRead the original at SEC EDGAR
Neutral

Viatris now owns Pacira, but paid about $1.69 billion before fees using cash and short-term borrowing. The filing gives no expected sales or profits to show whether Pacira's business outweighs the cost.

VTRS · Viatris Inc

AI read · Neutral

The AI's read

Owning Pacira adds its business to Viatris. Paying with cash and short-term borrowing also uses funds and adds borrowing. The filing gives no expected sales or profits from Pacira, so it does not show whether the added business outweighs the cost.

PCRX · Pacira BioSciences, Inc.

AI read · Good for PCRX

The connection

Pacira shareholders' shares were converted into rights to receive $36.50 each in cash. This gives them a definite payout, though Pacira no longer remains a separate public company.

Get alerts for VTRS

Follow Viatris Inc (VTRS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VTRS
Free on the App Store and Google Play, or on the web.